Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical Zymogens: Specificity and Steroidal Control of Reactivation.

Chembiochem : a European journal of chemical biology·2023
Same author

[Disinfectants during the COVID-19 pandemic: a challenge].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2021
Same author

Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options.

Journal of acquired immune deficiency syndromes (1999)·2019
Same author

Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort.

PloS one·2018
Same author

Is predictability salient? A study of attentional capture by auditory patterns.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2017
Same author

[Dysentery and amoebiasis in Poland in 2008].

Przeglad epidemiologiczny·2010

Related Experiment Video

Updated: Jun 10, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

[Hepatitis A in Poland in 2008].

Anna Baumann1

  • 1Zakład Epidemiologii, Narodowego Instytutu Zdrowia Publicznego - Państwowego Zakładu Higieny w Warszawie. abaumann@pzh.gov.pl

Przeglad Epidemiologiczny
|August 25, 2010
PubMed
Summary

Hepatitis A cases in Poland surged sixfold in 2008, with the lubelskie region most affected. Molecular characterization is recommended to track Hepatitis A Virus (HAV) strains and infection sources.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Context:

  • In 2008, Poland reported 208 hepatitis A cases, a significant increase from the previous year.
  • The national incidence rate was 0.55 per 100,000 population, six times higher than in 2007.

Purpose:

  • To analyze the epidemiological characteristics of hepatitis A in Poland in 2008.
  • To identify high-risk regions and age groups for hepatitis A infection.
  • To assess the contribution of imported cases and recommend diagnostic improvements.

Summary:

  • The incidence rate varied significantly by region, with lubelskie voivodeship at 3.51 and łódzkie voivodeship at 0.08.
  • Men aged 25-29 and 5-9 years, and women aged 0-4 and 5-9 years showed the highest incidence rates.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Experiment Videos

Last Updated: Jun 10, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

  • Approximately 29.8% of cases were imported from endemic countries; no deaths were reported.
  • Impact:

    • Highlights the need for enhanced surveillance and diagnostic tools, including molecular characterization of Hepatitis A Virus (HAV).
    • Provides crucial data for targeted public health interventions to control hepatitis A transmission in Poland.
    • Informing strategies to prevent future outbreaks and manage imported cases effectively.